* BioLife Solutions Inc BLFS.OQ reported a quarterly
adjusted
loss of 23 cents per share for the quarter ended in September.
The mean expectation of nine analysts for the quarter was for a
loss of 17 cents per share.
* Revenue rose 20.6% to $40.75 million from a year ago;
analysts
expected $42.06 million.
* BioLife Solutions Inc's reported EPS for the quarter was a
loss
of 23 cents.
* The mean earnings estimate of analysts had risen by
about 13.2%
in the last three months.
* In the last 30 days there have been no negative revisions
of
earnings estimates
* BioLife Solutions Inc shares had fallen by 10.5% this
quarter and lost 45.4% so far this year.
* The company reported a quarterly loss of $9.96 million.
* Wall Street's median 12-month price target for BioLife
Solutions
Inc is $31.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
9 at 10:42 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.17 -0.23 Missed
Jun. 30 2022 -0.21 -0.06 Beat
Mar. 31 2022 -0.25 -0.17 Beat
Dec. 31 2021 -0.17 -0.37 Missed